Calliditas Therapeutics Board Unanimously Recommends Acceptance Of Asahi Kasei's SEK 11.16B Tender Offer
Portfolio Pulse from Benzinga Newsdesk
Calliditas Therapeutics' Board has unanimously recommended that shareholders accept Asahi Kasei's SEK 11.16 billion tender offer. The offer includes a cash payment of SEK 208 per share and SEK 416 per American Depositary Share (ADS).
May 28, 2024 | 8:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Calliditas Therapeutics' Board has recommended that shareholders accept Asahi Kasei's SEK 11.16 billion tender offer, which includes SEK 208 per share and SEK 416 per ADS.
The unanimous recommendation by the Board to accept the tender offer is a strong indicator that the acquisition will likely proceed, which is generally positive for the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100